Simon Tremblay

1.0k total citations
25 papers, 669 citations indexed

About

Simon Tremblay is a scholar working on Transplantation, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Simon Tremblay has authored 25 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Transplantation, 5 papers in Surgery and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Simon Tremblay's work include Renal Transplantation Outcomes and Treatments (13 papers), Organ Transplantation Techniques and Outcomes (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Simon Tremblay is often cited by papers focused on Renal Transplantation Outcomes and Treatments (13 papers), Organ Transplantation Techniques and Outcomes (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Simon Tremblay collaborates with scholars based in United States, Canada and Australia. Simon Tremblay's co-authors include Rita R. Alloway, E. Steve Woodle, Joanne Weinberg, Qinghu Ren, Paul H. Roy, Liam D. H. Elbourne, Derek M. Harkins, Kisha Watkins, Robert J. Dodson and Sasha G. Tetu and has published in prestigious journals such as Blood, PLoS ONE and PLoS Medicine.

In The Last Decade

Simon Tremblay

24 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Tremblay United States 13 228 216 119 110 88 25 669
Erminio Torresani Italy 17 71 0.3× 90 0.4× 81 0.7× 20 0.2× 99 1.1× 40 771
K. Sack Germany 13 51 0.2× 86 0.4× 58 0.5× 49 0.4× 70 0.8× 76 620
Estela Monteiro Portugal 15 33 0.1× 149 0.7× 109 0.9× 25 0.2× 19 0.2× 52 668
A Penketh United Kingdom 15 67 0.3× 107 0.5× 323 2.7× 106 1.0× 32 0.4× 23 971
Kate Martin United Kingdom 11 79 0.3× 66 0.3× 149 1.3× 57 0.5× 3 0.0× 21 433
Toyoichiro Kudo Japan 16 25 0.1× 68 0.3× 278 2.3× 7 0.1× 39 0.4× 35 802
Gail Reid United States 13 21 0.1× 30 0.1× 84 0.7× 120 1.1× 12 0.1× 26 564
Lorenzo Zaffiri United States 12 24 0.1× 95 0.4× 88 0.7× 42 0.4× 5 0.1× 37 654
Nicholas Britt United States 12 22 0.1× 157 0.7× 42 0.4× 89 0.8× 21 0.2× 30 591
Sue Davies United Kingdom 12 8 0.0× 225 1.0× 122 1.0× 19 0.2× 13 0.1× 18 694

Countries citing papers authored by Simon Tremblay

Since Specialization
Citations

This map shows the geographic impact of Simon Tremblay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Tremblay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Tremblay more than expected).

Fields of papers citing papers by Simon Tremblay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Tremblay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Tremblay. The network helps show where Simon Tremblay may publish in the future.

Co-authorship network of co-authors of Simon Tremblay

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Tremblay. A scholar is included among the top collaborators of Simon Tremblay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Tremblay. Simon Tremblay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tremblay, Simon, Ashley R. Burg, Krishna M. Roskin, et al.. (2023). Effects of in vivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidates. American Journal of Transplantation. 23(6). 759–775. 2 indexed citations
2.
Woodle, E. Steve, Simon Tremblay, Rita R. Alloway, et al.. (2020). Plasma cell targeting to prevent antibody-mediated rejection. American Journal of Transplantation. 20. 33–41. 19 indexed citations
3.
Tremblay, Simon, Abbie D. Leino, Adele R. Shields, et al.. (2020). Reducing Donor-specific Antibody During Acute Rejection Diminishes Long-term Renal Allograft Loss: Comparison of Early and Late Rejection. Transplantation. 104(11). 2403–2414. 9 indexed citations
4.
Tremblay, Simon, James J. Driscoll, Adele R. Shields, et al.. (2019). A prospective, iterative, adaptive trial of carfilzomib-based desensitization. American Journal of Transplantation. 20(2). 411–421. 48 indexed citations
5.
Woodle, E. Steve, Simon Tremblay, Paul Brailey, et al.. (2019). Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells. American Journal of Transplantation. 20(2). 399–410. 22 indexed citations
6.
Ensor, Christopher R., et al.. (2019). Discharge medication procurement and education after kidney transplantation. Clinical Transplantation. 33(8). e13627–e13627. 4 indexed citations
7.
Shi, Tiffany, Adele R. Shields, Simon Tremblay, et al.. (2019). mTOR Inhibitor Therapy Diminishes Circulating CD8+ CD28− Effector Memory T Cells and Improves Allograft Inflammation in Belatacept-refractory Renal Allograft Rejection. Transplantation. 104(5). 1058–1069. 18 indexed citations
9.
Tremblay, Simon & Rita R. Alloway. (2017). Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations. The AAPS Journal. 19(5). 1332–1347. 19 indexed citations
10.
Alloway, Rita R., Alexander A. Vinks, Tsuyoshi Fukuda, et al.. (2017). Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial. PLoS Medicine. 14(11). e1002428–e1002428. 23 indexed citations
11.
Leroux, Audrey J., et al.. (2016). Mise à niveau d’un secteur pédiatrique de soins pharmaceutiques au Québec. Archives de Pédiatrie. 23(2). 117–127. 1 indexed citations
12.
Paterno, Flavio, Alin Girnita, Paul Brailey, et al.. (2016). Successful Simultaneous Liver-Kidney Transplantation in the Presence of Multiple High-Titered Class I and II Antidonor HLA Antibodies. Transplantation Direct. 2(12). e121–e121. 17 indexed citations
14.
Verret, Lucie, et al.. (2012). Impact of a Pharmacist‐Led Warfarin Self‐Management Program on Quality of Life and Anticoagulation Control: A Randomized Trial. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 32(10). 871–879. 61 indexed citations
15.
Roy, Paul H., Sasha G. Tetu, Liam D. H. Elbourne, et al.. (2010). Complete Genome Sequence of the Multiresistant Taxonomic Outlier Pseudomonas aeruginosa PA7. PLoS ONE. 5(1). e8842–e8842. 219 indexed citations
16.
Boctor, Fayez F., Jacques Renaud, Ángel Ruiz, & Simon Tremblay. (2009). Optimal and heuristic solution methods for a multiprocessor machine scheduling problem. Computers & Operations Research. 36(10). 2822–2828. 3 indexed citations
17.
Tremblay, Simon. (2007). Étude moléculaire du recrutement des gènes de résistance aux antibiotiques. Corpus Université Laval (Université Laval). 1 indexed citations
18.
Landry, Pierre, Simon Tremblay, Roger Darioli, & Blaise Genton. (2000). Inactivated hepatitis A vaccine booster given ≥24 months after the primary dose. Vaccine. 19(4-5). 399–402. 51 indexed citations
19.
Fortin, A., Nadia Berkova, Simon Tremblay, et al.. (1994). A specific false-positive 53 kDa signal in Western blot analysis using the enhanced-chemiluminescence system. Clinical Biochemistry. 27(3). 228–228. 1 indexed citations
20.
Rose, Timothy M., Simon Tremblay, & Edward W. Khandjian. (1992). Repression of a G0-associated 65-kilodalton protein in actively proliferating and SV40-transformed mouse kidney cells. Biochemistry and Cell Biology. 70(2). 149–155. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026